Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven O'Reilly

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Dermatology|June 9, 2023
Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesisThomas Steadman, Steven O'Reilly
Journal of Autoimmunity|July 28, 2020
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosisJulie C Worrell, Steven O'Reilly
Immunology Letters|February 21, 2018
Immunology and systemic sclerosis - EditorialSteven O'Reilly, Jacob M van Laar
Nature Reviews. Rheumatology|September 6, 2018
Targeting the TLR4-MD2 axis in systemic sclerosisSteven O'Reilly, Jacob M van Laar
Annals of the Rheumatic Diseases|November 30, 2021
Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosisJörg H W Distler, Steven O'Reilly
Nature Reviews. Rheumatology|February 5, 2016
Connective tissue diseases: Nucleosomes and systemic sclerosisSteven O'Reilly, Jacob M van Laar
Trends in Molecular Medicine|March 13, 2019
The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable TargetJohn Henderson, Joerg Distler, Steven O'Reilly
Cells|July 26, 2024
The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic SclerosisPaul Freedman, Bettina Schock, Steven O'Reilly
Epigenomics|April 28, 2017
CpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment responseSteven Horsburgh, Marzena Ciechomska, Steven O'Reilly
Experimental Dermatology|February 26, 2015
Current frontiers in systemic sclerosis pathogenesisMarzena Ciechomska, Jacob van Laar, Steven O'Reilly
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Dermatology|June 9, 2023
Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesisThomas Steadman, Steven O'Reilly
Journal of Autoimmunity|July 28, 2020
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosisJulie C Worrell, Steven O'Reilly
Immunology Letters|February 21, 2018
Immunology and systemic sclerosis - EditorialSteven O'Reilly, Jacob M van Laar
Nature Reviews. Rheumatology|September 6, 2018
Targeting the TLR4-MD2 axis in systemic sclerosisSteven O'Reilly, Jacob M van Laar
Annals of the Rheumatic Diseases|November 30, 2021
Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosisJörg H W Distler, Steven O'Reilly
Nature Reviews. Rheumatology|February 5, 2016
Connective tissue diseases: Nucleosomes and systemic sclerosisSteven O'Reilly, Jacob M van Laar
Trends in Molecular Medicine|March 13, 2019
The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable TargetJohn Henderson, Joerg Distler, Steven O'Reilly
Cells|July 26, 2024
The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic SclerosisPaul Freedman, Bettina Schock, Steven O'Reilly
Epigenomics|April 28, 2017
CpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment responseSteven Horsburgh, Marzena Ciechomska, Steven O'Reilly
Experimental Dermatology|February 26, 2015
Current frontiers in systemic sclerosis pathogenesisMarzena Ciechomska, Jacob van Laar, Steven O'Reilly
Pageof 9